Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape The rheumatoid arthritis ...
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...
A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell ...
Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This ...
Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and differentiated c-MET Inhibitor with ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...
CAR-T therapy demonstrates unique results in the treatment of oncological diseases – as stated by academician Sergei Krasny, the Deputy ...
Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defence, ...